Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families.

Disease markers - 1 Jan 2010

Cherbal Farid, Bakour Rabah, Adane Saida, Boualga Kada, Benais-Pont Gaelle, Maillet Philippe

Abstract excerpt

BACKGROUND: Breast cancer is the leading cause of cancer death in women in Algeria. The contribution of BRCA1 and BRCA2 mutations to hereditary breast/ovarian cancer in Algerian population is largely unknown. Here, we describe analysis of BRCA1 and BRCA2 genes in 86 individuals from 70 families from an Algerian cohort with a personal and family history suggestive of genetic predisposition to breast cancer....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis Regulatory Proteins
Share to Algeria
Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 Protein

Share to Germ-Line Mutation

Share to Mass Screening

Share to Ovarian Neoplasms

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 20683152
DOI: 10.3233/DMA-2010-0718
PMCID: PMC3833328

Genes

BRCA1
BRCA2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families.PMID 20683152Read ↗

BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.Semantic proximity Read ↗

BRCA1 and BRCA2 Germline Mutation Analysis in Hereditary Breast/Ovarian Cancer Families from the Aures Region (Eastern Algeria): First ReportSemantic proximity Read ↗

Identification of Eleven Novel BRCA Mutations in Tunisia: Impact on the Clinical Management of BRCA Related CancersSemantic proximity Read ↗

Mutational spectrum of BRCA1/2 genes in Moroccan patients with hereditary breast and/or ovarian cancer, and review of BRCA mutations in the MENA region.Semantic proximity Read ↗

Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancer.Semantic proximity Read ↗

Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.Semantic proximity Read ↗

BRCA1 and BRCA2 mutation testing in Cyprus; a population based study.Semantic proximity Read ↗

High-resolution melting (HRM) assay for the detection of recurrent BRCA1/BRCA2 germline mutations in Tunisian breast/ovarian cancer families.Semantic proximity Read ↗

Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia.Semantic proximity Read ↗

BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: Novel mutations and unclassified variantsSemantic proximity Read ↗

Novel and Recurrent BRCA1/BRCA2 Germline Mutations in Patients with Breast /Ovarian Cancer: A Series from the South of TunisiaSemantic proximity Read ↗

Screening of the BRCA1 gene in Brazilian patients with breast and/or ovarian cancer via high-resolution melting reaction analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.